Andlauer Healthcare Group Inc. (TSE:AND) Director Ronald Martin Skelton Sells 10,000 Shares of Stock

Andlauer Healthcare Group Inc. (TSE:ANDGet Free Report) Director Ronald Martin Skelton sold 10,000 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of C$42.75, for a total transaction of C$427,455.00.

Andlauer Healthcare Group Trading Down 0.7 %

AND opened at C$42.93 on Tuesday. The company has a debt-to-equity ratio of 33.79, a current ratio of 2.60 and a quick ratio of 1.66. The company’s 50 day simple moving average is C$42.26 and its two-hundred day simple moving average is C$45.55. Andlauer Healthcare Group Inc. has a 1-year low of C$40.16 and a 1-year high of C$55.85. The firm has a market capitalization of C$862.03 million, a price-to-earnings ratio of 25.71 and a beta of 0.67.

Andlauer Healthcare Group (TSE:ANDGet Free Report) last released its earnings results on Tuesday, August 1st. The company reported C$0.37 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.44 by C($0.07). Andlauer Healthcare Group had a return on equity of 16.57% and a net margin of 10.89%. The business had revenue of C$157.36 million during the quarter, compared to analysts’ expectations of C$167.00 million. Analysts expect that Andlauer Healthcare Group Inc. will post 1.7604515 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Royal Bank of Canada decreased their price target on shares of Andlauer Healthcare Group from C$46.00 to C$45.00 and set a “sector perform” rating on the stock in a research note on Thursday, August 3rd. TD Securities decreased their price target on shares of Andlauer Healthcare Group from C$58.00 to C$56.00 and set a “buy” rating on the stock in a research note on Thursday, August 3rd. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, Andlauer Healthcare Group has an average rating of “Moderate Buy” and a consensus price target of C$53.96.

Get Our Latest Stock Report on Andlauer Healthcare Group

About Andlauer Healthcare Group

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Featured Articles

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with's FREE daily email newsletter.